Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
Phase of Trial: Phase II
Latest Information Update: 08 May 2017
Price : $35 *
At a glance
- Drugs Mirtazapine (Primary)
- Indications Alcohol-related disorders; Major depressive disorder
- Focus Therapeutic Use
- Acronyms PT-MAD
- 24 Mar 2017 Status changed from active, no longer recruiting to completed.
- 07 Jan 2016 Planned End Date changed from 1 Aug 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.
- 07 Jan 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.